Not available
Quote | CASI Pharmaceuticals Inc. (NASDAQ:CASI)
Last: | $3.46 |
---|---|
Change Percent: | 2.59% |
Open: | $3.01 |
Close: | $3.46 |
High: | $3.55 |
Low: | $3.0068 |
Volume: | 34,449 |
Last Trade Date Time: | 05/22/2024 03:00:00 am |
News | CASI Pharmaceuticals Inc. (NASDAQ:CASI)
2024-05-21 09:13:41 ET More on Eli Lilly Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety Eli Lilly: Don't Overpay For Miracle Drugs Eli Lilly’s tirzepatide cleared for diabetes t...
2024-05-15 09:00:06 ET More on CASI Pharmaceuticals CASI stock rises on positive interim data from early stage trial for its NHL treatment in China Seeking Alpha’s Quant Rating on CASI Pharmaceuticals Historical earnings data for CASI Pharmaceuticals F...
Message Board Posts | CASI Pharmaceuticals Inc. (NASDAQ:CASI)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CASI News Article - CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESUL | whytestocks | investorshangout | 08/12/2022 12:01:14 PM |
znewcar1: CASI 29% v5,1M c3.90 f13,6M H4.73 ML2.24 YL2.28 | znewcar1 | investorshangout | 08/12/2022 1:54:57 AM |
whytestocks: $CASI News Article - CASI PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT | whytestocks | investorshangout | 05/26/2022 8:37:00 PM |
whytestocks: $CASI News Article - CASI PHARMACEUTICALS ANNOUNCES STOCK REPURCHASE PROGRAM | whytestocks | investorshangout | 12/17/2021 4:30:50 PM |
Nice pop afterhours. | Ichauway | investorshub | 11/20/2021 3:12:59 AM |
News, Short Squeeze, Breakout and More Instantly...
CASI Pharmaceuticals Inc. Company Name:
CASI Stock Symbol:
NASDAQ Market:
CASI Pharmaceuticals Inc. Website:
CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP) PR Newswire BEIJING , May 15, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company sp...
CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTS PR Newswire BEIJING , May 14, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializin...
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS PR Newswire BEIJING , April 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercia...